"Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung

Journal of Virology
M CroyleJ M Wilson

Abstract

Most of the early gene therapy trials for cystic fibrosis have been with adenovirus vectors. First-generation viruses with E1a and E1b deleted are limited by transient expression of the transgene and substantial inflammatory responses. Gene transfer is also significantly curtailed following a second dose of virus. In an effort to reduce adenovirus-associated inflammation, capsids of first-generation vectors were modified with various activated monomethoxypolyethylene glycols. Cytotoxic T-lymphocyte production was significantly reduced in C57BL/6 mice after a single intratracheal administration of modified vectors, and length of gene expression was extended from 4 to 42 days. T-cell subsets from mice exposed to the conjugated vectors demonstrated a marked decrease in Th1 responses and slight enhancement of Th2 responses compared to animals dosed with native virus. Neutralizing antibodies (NAB) against adenovirus capsid proteins were reduced in serum and bronchoalveolar lavage fluid of animals after a single dose of modified virus, allowing significant levels of gene expression upon rechallenge with native adenovirus. Modification with polyethylene glycol (PEG) also allowed substantial gene expression from the new vectors in anim...Continue Reading

References

Jan 1, 1985·International Journal of Immunopharmacology·J TsujiI Yamamoto
Apr 1, 1973·Virology·F L Graham, A J van der Eb
May 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·Y YangJ M Wilson
Apr 25, 1995·Proceedings of the National Academy of Sciences of the United States of America·K MitaniS Kochanek
Mar 1, 1995·Trends in Biotechnology·Y InadaA Matsushima
May 2, 1996·The New England Journal of Medicine·J M Wilson
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·M A KayC B Wilson
Mar 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·Y IlanM S Horwitz
Jul 31, 1998·Hematology/oncology Clinics of North America·D H StermanS M Albelda
Oct 6, 1998·Clinics in Chest Medicine·C B Robinson
Aug 17, 1999·Current Opinion in Immunology·W S WoldA E Tollefson
Aug 17, 1999·Current Opinion in Biotechnology·G DeSantis, J B Jones
Oct 6, 1999·Current Opinion in Biotechnology·K BenihoudM Perricaudet

❮ Previous
Next ❯

Citations

Jan 15, 2004·American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions·Mary Jayne Kennedy
Apr 14, 2006·Cancer Immunology, Immunotherapy : CII·Susan J HedleyImre Kovesdi
Feb 14, 2007·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Gang NiuXiaoyuan Chen
Jul 5, 2008·Clinical Reviews in Allergy & Immunology·Christian Mueller, Terence R Flotte
Mar 11, 2005·Advanced Drug Delivery Reviews·Zhi-Li XuTakao Hayakawa
Nov 30, 2002·Advanced Drug Delivery Reviews·Stefano FerrariEric W F W Alton
Sep 9, 2010·Molecular Pharmaceutics·Piyanuch WongananMaria A Croyle
Dec 4, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Nicola Brunetti-PierriPhilip Ng
May 8, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sean E HofherrMichael A Barry
Jun 11, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Marcio O Lasaro, Hildegund C J Ertl
Jun 17, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Byram W BridleYonghong Wan
Jun 2, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jae-Hyung JangLonnie D Shea
Mar 1, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Mayumi OaklandPaul B McCray
Mar 16, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Joseph D MocanuFei-Fei Liu
Jan 7, 2003·Nature Medicine·Thomas J Wickham
Nov 19, 2005·Nature Reviews. Cancer·Kelley A ParatoJohn C Bell
Jun 17, 2008·Nature Reviews. Microbiology·Roberto CattaneoMichael A Barry
Oct 19, 2005·Gene Therapy·R AlbaM Chillon
Jan 20, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Terence R FlotteJim Hu
Feb 8, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Nicola Brunetti-PierriPhilip Ng
Sep 13, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Andreas WortmannFlorian Kreppel
Oct 4, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Florian Kreppel, Stefan Kochanek
Mar 20, 2003·Journal of Cardiac Surgery·Andrew H Baker
Jul 29, 2004·Viral Immunology·Saroj K BasakMichael D Roth
Feb 28, 2013·Human Gene Therapy Methods·Vedell Louis JeuneThomas Weber
Dec 22, 2004·Human Gene Therapy·Michael J McConnell, Michael J Imperiale
Dec 22, 2004·Human Gene Therapy·Hiroyuki Mizuguchi, Takao Hayakawa
Feb 3, 2005·Human Gene Therapy·Daniel A Muruve
Mar 12, 2005·Human Gene Therapy·Dan H Barouch, Gary J Nabel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.